NCT00005864View on ClinicalTrials.gov

Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2000

Study Completion Date

February 29, 2004

Conditions
Colorectal Cancer
Interventions
DRUG

chloroquinoxaline sulfonamide

Trial Locations (4)

40503

Central Baptist Hospital, Lexington

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

48109-0752

University of Michigan Comprehensive Cancer Center, Ann Arbor

43210-1240

Arthur G. James Cancer Hospital - Ohio State University, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT00005864 - Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer | Biotech Hunter | Biotech Hunter